Literature DB >> 21507509

[Intravitreal bevacizumab treatment for choroidal neovascularization in Best's disease].

J Perol1, B Wolff, J-A Sahel, Y Le Mer.   

Abstract

Best's disease is an autosomal-dominant macular dystrophy, which might lead to choroidal neovascularization. The case of a 9-year-old boy followed up for a Best's disease is hereby reported. The boy was referred to our service department for a decrease in visual acuity in his right eye. Ophthalmoscopic examination revealed a foveolar vitelliform lesion, complicated by a choroidal neovascularization. The patient received a single intravitreal bevacizumab injection, which led to a complete resolution of intraretinal fluid and a significant reduction in neovascularization size. Visual acuity also improved. This case underlines the efficiency efficacy of intravitreal anti-VEGF therapy for choroidal neovascularization in Best's disease.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21507509     DOI: 10.1016/j.jfo.2010.11.021

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  1 in total

1.  Evolution of Choroidal Neovascular Membrane in Best Disease after Single Intravitreal Bevacizumab. Case Report.

Authors:  Christiana Celea; Mihai Pop; Nicoleta Avidis-Zamfiroiu; Cristian Celea
Journal:  Maedica (Buchar)       Date:  2015-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.